行情

GILD

GILD

吉利德科技
NASDAQ

实时行情|Nasdaq Last Sale

64.91
-0.32
-0.49%
盘后: 64.62 -0.29 -0.45% 18:40 10/18 EDT
开盘
65.40
昨收
65.23
最高
65.45
最低
64.20
成交量
880.56万
成交额
--
52周最高
75.60
52周最低
60.32
市值
822.06亿
市盈率(TTM)
14.02
分时
5日
1月
3月
1年
5年

分析师评级

28位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

GILD 新闻

  • Will Soliris Aid Growth for Alexion (ALXN) in Q3 Earnings?
  • Zacks.1天前
  • New Gilead CFO: Let's Make a Deal
  • GuruFocus.com.1天前
  • Will Strong HIV Sales Drive Gilead's (GILD) Q3 Earnings?
  • Zacks.1天前
  • Factors Setting the Tone for Novartis' (NVS) Q3 Earnings
  • Zacks.1天前

更多

所属板块

生物技术和医学研究
-1.17%
制药与医学研究
-0.94%

热门股票

名称
价格
涨跌幅

GILD 简况

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.
展开

Webull提供Gilead Sciences, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。